Manejo adecuado en pacientes adultos con fibrosis pulmonar
Fecha
2018
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Medicina
Resumen
La fibrosis pulmonar pertenece al grupo de las enfermedades pulmonares intersticiales difusas; es de causa desconocida, con mal pronóstico y escasas opciones terapéuticas, afecta generalmente a varones mayores de 50 años y cursa con disnea de esfuerzo y tos seca; en los últimos años se ha observado un incremento de la prevalencia, probablemente debido a la optimización de los métodos diagnósticos y al aumento de la esperanza de vida. El método de investigación es de enfoque cuantitativo, diseño no experimental, de corte transversal retrospectivo, el método es observacional, descriptivo y analitico por lo cual se analizaron las historias clínicas de cada uno de los pacientes recolectando información detallada de cada caso. Se pudo demostrar la prevalencia de la fibrosis pulmonar en el Hospital Martin Icaza durante el año 2017, la cual es de aproximadamente 0,03%, de acuerdo a los factores de riesgo que se encontraron en estos tenemos que el 59% tienen antecedentes de tabaquismo, 24% de estos se vieron afectados por el medio donde desenvuelven su vida cotidianamente, el 9% pertenece a pacientes fumadores pasivos, un 8% no presentó un factor de riesgo aparente el cual hace pensar en algún factor de tipo genético y además se pudo obtener el grupo etario de los pacientes atendidos con Fibrosis pulmonar, que es de 65 en adelante mayoritariamente en edades de 72 años y el género más afectado fue el masculino con el 65% de los casos.
pulmonary fibrosis belongs to the group of diffuse interstitial lung diseases; it is of unknown cause, with poor prognosis and scarce therapeutic options, it generally affects men over 50 years of age and presents with dyspnea on exertion and dry cough; In recent years, an increase in prevalence has been observed, probably due to the optimization of diagnostic methods and the increase in life expectancy. The research method is a approach, non-experimental design, retrospective cross section, the method is observational, analytical and descriptive, so the clinical histories of each of the patients were analyzed, collecting detailed information on each case. It was possible to demonstrate the prevalence of pulmonary fibrosis in the Hospital Martin Icaza during the year 2017, which is approximately 0.03%, according to the risk factors found in these we have that 59% have a history of smoking, 24% of these were affected by the environment where they live their daily lives, 9% belong to passive smokers, 8% did not present an apparent risk factor which suggests a factor of genetic type and also It was possible to obtain the age group of patients treated with pulmonary fibrosis, which is 65 years and older, mainly at the age of 72 years and the most affected gender was male, with 65% of cases.
pulmonary fibrosis belongs to the group of diffuse interstitial lung diseases; it is of unknown cause, with poor prognosis and scarce therapeutic options, it generally affects men over 50 years of age and presents with dyspnea on exertion and dry cough; In recent years, an increase in prevalence has been observed, probably due to the optimization of diagnostic methods and the increase in life expectancy. The research method is a approach, non-experimental design, retrospective cross section, the method is observational, analytical and descriptive, so the clinical histories of each of the patients were analyzed, collecting detailed information on each case. It was possible to demonstrate the prevalence of pulmonary fibrosis in the Hospital Martin Icaza during the year 2017, which is approximately 0.03%, according to the risk factors found in these we have that 59% have a history of smoking, 24% of these were affected by the environment where they live their daily lives, 9% belong to passive smokers, 8% did not present an apparent risk factor which suggests a factor of genetic type and also It was possible to obtain the age group of patients treated with pulmonary fibrosis, which is 65 years and older, mainly at the age of 72 years and the most affected gender was male, with 65% of cases.
Descripción
PDF
Palabras clave
Fibrosis pulmonar, Estudios retrospectivos, Epidemiología descriptiva, Epidemiología analítica, Hospital General Martín Icaza, Cantón Babahoyo, Ecuador, Adulto